Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin

Drug Development and Industrial Pharmacy

Volumn 37, Issue 4, 2011, Pages 419-427

  Huang, Xin ^a   Wu, Zhenghong ^a   Gao, Wei ^a   Chen, Qin ^a   Yu, Bin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; in vitro release; PAMAM dendrimers; pharmacokinetics; silybin; silybin PAMAM complex; solubilization

Indexed keywords

DENDRIMER; DRUG CARRIER; POLYAMIDOAMINE; SILIBININ;

AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG RELEASE; IN VITRO STUDY; PH; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE DRUG DOSE; SOLUBILIZATION;

ANIMALS; BIOLOGICAL AVAILABILITY; DENDRIMERS; DRUG CARRIERS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; SILYMARIN; SOLUBILITY;

EID: 79953236654     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.518150     Document Type: Article

References (30)

1. Tomalia DA, Baker H, Dewald J, Hall MGK, Martin S, Roeck J, et al. (1985). A new class of polymers: Starburst-dendritic macromolecules. Polym J, 17:117-32.
2. Caminade A, Laurent R, Majoral J (2005). Characterization of dendrimers. Adv Drug Deliv Rev, 57:2130-46. (Pubitemid 41759390)
3. Tomalia DA (2005). Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci, 30:294-324. (Pubitemid 40642933)
4. Svenson S, Tomalia DA (2005). Dendrimers in biomedical applications- reflections on the field. Adv Drug Deliv Rev, 57:2106-29. (Pubitemid 41759389)
5. Gupta U, Agashe HB, Asthana A, Jain NK (2006). Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules, 7:649-58.
6. Najlah M, Freeman S, Attwood D, D'Emanuele A (2006). Synthesis, characterization and stability of dendrimer prodrugs. Int J Pharm, 308:175-82. (Pubitemid 43097250)
7. Tang SZ, June SM, Howell BA, Chai MH (2006). Synthesis of salicylate dendritic prodrugs. Tetrahedron Lett, 47:7671-5. (Pubitemid 44472528)
8. Weilun K, Yansong Z, Rongqin H, Chen J, Yuanying P (2008). Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J Pharm Sci, 97:2208-16.
9. Fant K, Esbjörner EK, Jenkins A, Grossel MC, Lincoln P, Nordén B (2008). DNA condensation by PAMAM dendrimers: Selfassembly characteristics and effect on transcription. Biochemistry, 47:1732-40. (Pubitemid 351231222)
10. Rongqin H, Weilun K, Yang L, Chen J, Yuanying P (2008). The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials, 29:238-46.
11. Hye YN, Kihoon N, Hwa JH, Bo HK, Hyun JL, Hyun JK, et al. (2009). Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity. Biomaterials, 30:665-73.
12. Yiyun C, Haiou Q, Minglu M, Zhenhua X, Peng X, Yujie F, et al. (2007). Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study. Eur J Med Chem, 42:1032-8.
13. Renu SD, Patrice H (2007). Influence of molecular architecture of polyether-co-polyester dendrimers on the encapsulation and release of methotrexate. Biomaterials, 28:3140-52.
14. Papagiannaros A, Dimas K, Papaioannou GT, Demetzos C (2005). Doxorubicin-PAMAM dendrimer complex attached to liposomes: Cytotoxic studies against human cancer cell lines. Int J Pharm, 302:29-38. (Pubitemid 41242749)
15. Kitchens KM, El-Sayed ME, Ghandehari H (2005). Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev, 57:2163-76. (Pubitemid 41759391)
16. Kvasnicka F, Biba B, Sevcik R, Voldrich M, Kratka J (2003). Analysis of the active components of silymarin. J Chromatogr A, 990:239-45. (Pubitemid 36293880)
17. Tedesco D, Tava A, Galletti S, Tameni M, Varisco G, Costa A, et al. (2004). Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows. J Dairy Sci, 87:2239-47. (Pubitemid 38978827)
18. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E (1990). Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet, 15:333-8.
19. Morazzoni P, Magistretti MJ, Giachetti C, Zanolo G (1992). Comparative bioavailability of silipide, a new flavanolignan complex, in rats. Eur J Drug Metab Pharmacokinet, 17:39-44.
20. Bharathi D, Ronald AH, Melgardt MV (2004). The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm, 284:133-40.
21. Devarakonda B, Hill RA, Liebenberg W, Brits M, de Villiers MM (2005). Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int J Pharm, 304:193-209. (Pubitemid 41427662)
22. Broeren MAC, de Waal BF, Van Genderen MH, Sanders HM, Fytas G, Meijer EW (2005). Multicomponent host-guest chemistry of carboxylic acid and phosphonic acid based guests with dendritic hosts: An NMR study. J Am Chem Soc, 127, 10334-43. (Pubitemid 41051062)
23. Boisselier E, Ornelas C, Pianet I, Aranzaes JR, Astruc D (2008). Four Generations of water-soluble dendrimers with 9-243 benzoate tethers: Synthesis and dendritic effects on their ion pairing with acetylcholine, benzyltriethylammonium, and dopamine in water. Chemistry, 14:5577-87.
24. Yiyun C, Qinglin W, Yiwen L, Tongwen X (2008). External electrostatic interaction versus internal encapsulation between cationic dendrimers and negatively charged drugs: Which contributes more to solubility enhancement of the drugs? J Phys Chem B, 112:8884-90.
25. Jingjing H, Yiyun C, Yanrui M, Qinglin W, Tongwen X (2009). Host-guest chemistry and physicochemical properties of the dendrimer-mycophenolic acid complex. J Phys Chem B, 113:64-74.
26. Jevprasesphant R, Penny J, Attwood D, McKeown NB, D'Emanuele A (2003). Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res, 20:1543-50. (Pubitemid 37268266)
27. Devarakonda B, Hill RA, de Villiers MM (2004). The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm, 284:133-40. (Pubitemid 39349146)
28. Yulian L, Takeo F, Naoko K, Yuiko T, Mariko N, Dong Z, et al. (2010). Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats. J Control Release, doi:10.1016/ j.jconrel.2010.02.017.
29. Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H (2007). Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem, 18:2054-60. (Pubitemid 350220008)
30. Kitchens KM, Kolhatkar RB, Swaan PW, Eddington ND, Ghandehari H (2006). Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling. Pharm Res, 23:2818-26. (Pubitemid 44885368)